[1]RIZWANI W,ALEXANDROW M,CHELLAPPAN S.Prohibitin physically interacts with MCM proteins and inhibits mammalian DNA replication[J].Cell Cycle,2009,8(10):1621-1629.
|
[2]THEISS AL,SITARAMAN SV.The role and therapeutic potential of prohibitin in disease[J].Biochim Biophys Acta,2011,1813(6):1137-1143.
|
[3]EMERSON V,HOLTKOTTE D,PFERIFFER T,et al.Identification of the cellular prohibitin 1/prohibitin 2 heterodimer as an interaction partner of the C-terminal cytoplasmic domain of the HIV-1 glycoprotein[J].J Virol,2010,84(3):1355-1365.
|
[4]LOPEZ-HUERTAS MR,MATEOS E,SNCHEZ DEL COJO M,et al.The presence of HIV-1 Tat protein second exon delays fas protein-mediated apoptosis in CD4+T lymphocytes:a potential mechanism for persistent viral production[J].J Biol Chem,2013,288(11):7626-7644.
|
[5]LIU C,ZHANG A,GUO J,et al.Identification of human host proteins contributing to H5N1 influenza virus propagation by membrane proteomics[J].J Proteome Res,2012,11(11):5396-5405.
|
[6]ROGEE S,LE GALL M,CHAFEY P,et al.Quantitative proteomics identifies host factors modulated during acute hepatitis E virus infection in the swine model[J].J Virol,2015,89(1):129-143.
|
[7]LIU S,WANG W,BROWN LE,et al.A novel class of small molecule compounds that inhibit hepatitis C virus infection by targeting the prohibitin-CRaf pathway[J].EBio Medicine,2015,2(11):1600-1606.
|
[8] SUN MZ,DANG SS.Research progress of prohibitin in liver disease[J/CD].Chin J Liver Dis:Electronic Edition,2011,3(2):61-64.(in Chinese)孙明珠,党双锁.抗增殖蛋白在肝脏疾病中的研究进展[J/CD].中国肝脏病杂志:电子版,2011,3(2):61-64.
|
[9]TSUTSUMI T,MATSUDA M,AIZAKI H,et al.Proteomics analysis of mitochondrial proteins reveals overexpression of a mitochondrial protein chaperon,prohibitin,in cells expressing hepatitis C virus core protein[J].Hepatology,2009,50(2):378-386.
|
[10]MOHD HANAFIAH K,GROEGER J,FLAXMAN AD,et al.Global epidemiology of hepatitis C virus infection:new estimates of age-specific antibody to HCV seroprevalence[J].Hepatology,2013,57(4):1333-1342.
|
[11]LINDENBACH BD,EVANS MJ,SYDER AJ,et al.Complete replication of hepatitis C virus in cell culture[J].Science,2005,309(22):623-626.
|
[12]QIAN X,XU C,ZHAO P,et al.Long non-coding RNA GAS5inhibited hepatitis C virus replication by binding viral NS3 protein[J].Virology,2016,492:155-165.
|
[13]LIU S,HAO Q,PENG N,et al.Major vault protein:a virus-induced host factor against viral replication through the induction of type-Ⅰinterferon[J].Hepatology,2012,56(1):57-66.
|
[14]SANCHEZ-QUILES V,SANTAMARIA E,SEQURA V,et al.Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells:molecular mechanisms and functional implications[J].Proteomics,2010,10(8):1609-1620.
|
[15]CHENG J,GAO F,CHEN X,et al.Prohibitin-2 promotes hepatocellular carcinoma malignancy progression in hypoxia based on a label-free quantitative proteomics strategy[J].Mol Carcinog,2014,53(10):820-832.
|
[16] DANG SS,SUN MZ,XUN M,et al.Expression of prohibitin in hunman liver cancer cells SMMC-7721 and Huh-7 and amplification of prohibitin coding sequence[J/CD].Chin J Liver Dis:Electronic Edition,2010,2(3):1-5.(in Chinese)党双锁,孙明珠,寻萌,等.抑制素在人肝癌细胞SMMC-7721和Huh-7中的表达及其编码序列扩增[J/CD].中国肝脏病杂志:电子版,2010,2(3):1-5.
|
[17]ZHAO W,WANG L,CHEN P,et al.7-aa peptide mimic from HVR1 of HCV protects hepatic injury in rats by reduced expression of key pro-inflammatory factors[J].Inflamm Allergy Drug Targets,2010,9(2):135-145.
|